Apremilast

CAS 608141-41-9

Overview

Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. It may also be useful for other immune system related inflammatory diseases

Anant Labs manufacture and furnish high quality Apremilast impurities for global markets. Our Apremilast EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Apremilast

Cat. No. ANTPRD5713Old No. ANT-APM-00CAS 608141-41-9In Stock

Technical Data

New Cat. No.ANTPRD5713

Old Cat. No.ANT-APM-00

CAS608141-41-9

Mol. FormulaC₂₂H₂₄N₂O₇S

Mol. Weight460.5 g/mol

IUPACN-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide

SMILESCCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC

InChIInChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1

InChI KeyIMOZEMNVLZVGJZ-QGZVFWFLSA-N

Synonyms

(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dioneApremilast608141-41-9OTEZLACC-10004CC 10004CC10004apremilastumCHEBI:78540UP7QBP99PN